OBMP
US OTC
Theralink Technologies Inc
Overview
OBMP
Symbol
US OTC
Exchange
About stock

Theralink Technologies, Inc., a commercial-stage precision medicine and molecular data-generating company, engages in the development and commercialization of novel cancer immunotherapy products. The company through its patented phosphoprotein and protein biomarker platform and LDTs technology targets multiple areas of oncology and drug development; and provides precision oncology data through its Theralink Reverse Phase Protein Array assays to assist the biopharmaceutical industry and clinical oncologists in identifying likely responders and non-responders to FDA-approved and investigational drug treatments. Its data-generating assays provide actionable information for physicians, patients, and biopharmaceutical companies in the area of oncology.

The company was formerly known as OncBioMune Pharmaceuticals, Inc. and changed its name to Theralink Technologies, Inc. in September 2020.

Theralink Technologies Inc dividend calculator
Report issue